Products and
Pipeline


logo

Exkivity (Mobocertinib)

EXKIVITYTM (mobocertinib) is a kinase inhibitor indicated for the treatment of adult patients with locally..

logo

Alunbrig (Brigatinib)

ALUNBRIG® (brigatinib) is indicated for the treatment of adult patients with anaplastic lymphoma ki…

logo

Iclusig (Ponatinib)

ICLUSIG® (ponatinib) is now indicated for adult patients with chronic phase-CML who are…

logo

Ninlaro (Ixazomib)

NINLARO® (ixazomib) is the first and only oral medication of its kind, a proteasome inhibitor, that…

logo

Velcade (bortezomib)

VELCADE® (bortezomib) belongs to a class of medicines called proteasome inhibitors. It is approved by the…

phase 1

phase 2

phase 3

phase 4

Hematologic Malignancies

Hematologic Malignancies

Solid Tumors

Hematologic Malignancies

Hematologic Malignancies

Hematologic Malignancies

Other Solid Tumors

Other Solid Tumors